E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer

Clinical trial NCT04476251 · TERMINATED

Trial details

NCT number: NCT04476251
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Uterine Cervical Neoplasms

Start date: 2021-01-14
Primary completion: 2021-09-15
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.